跳至主要内容
临床试验/NCT02390297
NCT02390297进行中(未招募)不适用

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct

Calimmune, Inc.2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
11
试验地点
2
主要终点
Detection of delayed clinical or molecular adverse events related to Cal-1, or the associated delivery procedures

研究概览

简要总结

Long term safety follow-up of Cal-1 recipients

详细描述

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46 (Cal-1), a Dual Anti-HIV Gene Transfer Construct

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Previous treatment with the Cal-1 modified hematopoietic cellular products

排除标准

  • Inability to understand and provide informed consent

结局指标

主要结局

Detection of delayed clinical or molecular adverse events related to Cal-1, or the associated delivery procedures

时间窗: 15 years

次要结局

  • Assessment of the long term survival and activity of Cal-1 modified hematopoietic cells through evaluation of Cal-1 marking and expression in peripheral blood(15 yars)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验